News

Discovery Explaining the Potential Cardiovascular Benefits of a Precision Therapy Based on the Genetic Profile

April 27, 2018

Researchers at the Montreal Heart Institute announced today that they have discovered the mechanism for the protective effects of reduced activity of the ADCY9 gene in atherosclerosis resulting from accumulation of fat in the artery walls. Indeed, a reduction of 65% of atherosclerosis occurs when the ADCY9 gene is not functional in mice, but only when another gene (CETP) is also absent. This benefit is explained by a marked reduction of inflammation in the arteries. These results have been published in the prestigious American scientific journal Circulation.

Read more

Ceapro Inc. Announces Important Collaboration with Prestigious Montreal Heart Institute

April 19, 2018

Ceapro Inc. (TSX-V: CZO), a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, announced today that it has established a long-term formal collaboration with the prestigious Montreal Heart Institute (MHI).

Read more